Fibrates modify the expression of key factors involved in bile-acid synthesis and biliary-lipid secretion in gallstone patients

Author： Roglans Núria   Vázquez-Carrera Manuel   Alegret Marta   Novell Ferran   Zambón Daniel   Ros Emilio   Laguna Juan   Sánchez Rosa  

Publisher： Springer Publishing Company

ISSN： 0031-6970

Source： European Journal of Clinical Pharmacology, Vol.59, Iss.12, 2004-02, pp. : 855-861

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Drugs Affecting Biliary Lipid Secretion and Gallbladder Motility: Their Potential Role in Gallstone Treatment and Prevention

By  

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 5, Iss. 2, 2005-06 ,pp. : 185-191

Bentham Science Publishers

Access to resources Recommend Favorite

FXR, A Therapeutic Target for Bile Acid and Lipid Disorders

By  

Mini Reviews in Medicinal Chemistry, Vol. 5, Iss. 8, 2005-08 ,pp. : 719-727

Bentham Science Publishers

Access to resources Recommend Favorite

Potential New Approaches to Modifying Intestinal GLP-1 Secretion in Patients with Type 2 Diabetes Mellitus: Focus on Bile Acid Sequestrants

By >  

Clinical Drug Investigation, Vol. 32, Iss. 1, 2012-01 ,pp. : 1-14

Adis International

Access to resources Recommend Favorite

Fibrates suppress chenodeoxycholic acid-induced RANTES expression through inhibition of NF- B activation

By Hirano Y.   Hirano F.   Fujii H.   Makino I.  

European Journal of Pharmacology, Vol. 448, Iss. 1, 2002-07 ,pp. : 19-26

Elsevier

Access to resources Recommend Favorite

Effects of Fatty Acid Bile Acid Conjugates (FABACs) on Biliary Lithogenesis: Potential Consequences for Non-Surgical Treatment of Gallstones

By  

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 5, Iss. 2, 2005-06 ,pp. : 171-175

Bentham Science Publishers

Access to resources Recommend Favorite